Autocrine Activation of the Wnt/b-Catenin Pathway by CUX1 and GLIS1 in Breast Cancers

Biology Open

Volumn 3, Issue 10, 2014, Pages 937-946

  Vadnais, Charles ^a,b   Shooshtarizadeh, Peiman ^a   Rajadurai, Charles V ^a,b   Lesurf, Robert ^a,b,c   Hulea, Laura ^a,b   Davoudi, Sayeh ^a   Cadieux, Chantal ^b   Hallett, Michael ^a,c   Park, Morag ^a,b   Nepveu, Alain ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Breast cancer; Expression profiling; Mouse tumor model; Transcriptional regulation; Wnt b Catenin pathway

Indexed keywords

EID: 84979266946     PISSN: None     EISSN: 20466390     Source Type: Journal    
DOI: 10.1242/bio.20148193     Document Type: Article

References (66)

1. Abraham, G., Kowalczyk, A., Loi, S., Haviv, I. and Zobel, J. (2010). Prediction of breast cancer prognosis using gene set statistics provides signature stability and biological context. BMC Bioinformatics 11, 277.
2. Akiri, G., Cherian, M. M., Vijayakumar, S., Liu, G., Bafico, A. and Aaronson, S. A. (2009). Wnt pathway aberrations including autocrine Wnt activation occur at high frequency in human non-small-cell lung carcinoma. Oncogene 28, 2163-2172.
3. Bafico, A., Liu, G., Goldin, L., Harris, V. and Aaronson, S. A. (2004). An autocrine mechanism for constitutive Wnt pathway activation in human cancer cells. Cancer Cell 6, 497-506.
4. Benhaj, K., Akcali, K. C. and Ozturk, M. (2006). Redundant expression of canonical Wnt ligands in human breast cancer cell lines. Oncol. Rep. 15, 701-707.
5. Cadieux, C., Kedinger, V., Yao, L., Vadnais, C., Drossos, M., Paquet, M. and Nepveu, A. (2009). Mouse mammary tumor virus p75 and p110 CUX1 transgenic mice develop mammary tumors of various histologic types. Cancer Res. 69, 7188-7197.
6. Cancer Genome Atlas Network. (2012). Comprehensive molecular portraits of human breast tumours. Nature 490, 61-70.
7. Chen, Y., Goodman, R. H. and Smolik, S. M. (2000). Cubitus interruptus requires Drosophila CREB-binding protein to activate wingless expression in the Drosophila embryo. Mol. Cell. Biol. 20, 1616-1625.
8. Chen, B., Dodge, M. E., Tang, W., Lu, J., Ma, Z., Fan, C. W., Wei, S., Hao, W., Kilgore, J., Williams, N. S. et al. (2009a). Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer. Nat. Chem. Biol. 5, 100-107.
9. Chen, M., Wang, J., Lu, J., Bond, M. C., Ren, X. R., Lyerly, H. K., Barak, L. S. and Chen, W. (2009b). The anti-helminthic niclosamide inhibits Wnt/Frizzled1 signaling. Biochemistry 48, 10267-10274.
10. Couso, J. P., Bishop, S. A. and Martinez Arias, A. (1994). The wingless signalling pathway and the patterning of the wing margin in Drosophila. Development 120, 621-636.
11. Cubelos, B., Sebastián-Serrano, A., Beccari, L., Calcagnotto, M. E., Cisneros, E., Kim, S., Dopazo, A., Alvarez-Dolado, M., Redondo, J. M., Bovolenta, P. et al. (2010). Cux1 and Cux2 regulate dendritic branching, spine morphology, and synapses of the upper layer neurons of the cortex. Neuron 66, 523-535.
12. Dahmane, N., Lee, J., Robins, P., Heller, P. and Ruiz i Altaba, A. (1997). Activation of the transcription factor Gli1 and the Sonic hedgehog signalling pathway in skin tumours. Nature 389, 876-881.
13. Dann, C. E., Hsieh, J. C., Rattner, A., Sharma, D., Nathans, J. and Leahy, D. J. (2001). Insights into Wnt binding and signalling from the structures of two Frizzled cysteine-rich domains. Nature 412, 86-90.
14. de Celis, J. F. and Bray, S. (1997). Feed-back mechanisms affecting Notch activation at the dorsoventral boundary in the Drosophila wing. Development 124, 3241-3251.
15. DiMeo, T. A., Anderson, K., Phadke, P., Fan, C., Perou, C. M., Naber, S. and Kuperwasser, C. (2009). A novel lung metastasis signature links Wnt signaling with cancer cell self-renewal and epithelial-mesenchymal transition in basal-like breast cancer. Cancer Res. 69, 5364-5373.
16. Esserman, L. J., Berry, D. A., Cheang, M. C., Yau, C., Perou, C. M., Carey, L., DeMichele, A., Gray, J. W., Conway-Dorsey, K., Lenburg, M. E. et al.; I-SPY1 TRIAL Investigators. (2012). Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657). Breast Cancer Res. Treat. 132, 1049-1062.
17. Fiaschi, M., Rozell, B., Bergström, A. and Toftgård, R. (2009). Development of mammary tumors by conditional expression of GLI1. Cancer Res. 69, 4810-4817.
18. Glück, S., Ross, J. S., Royce, M., McKenna, E. F., Jr, Perou, C. M., Avisar, E. and Wu, L. (2012). TP53 genomics predict higher clinical and pathologic tumor response in operable early-stage breast cancer treated with docetaxelcapecitabine 6 trastuzumab. Breast Cancer Res. Treat. 132, 781-791.
19. Goulet, B., Watson, P., Poirier, M., Leduy, L., Bérubé, G., Meterissian, S., Jolicoeur, P. and Nepveu, A. (2002). Characterization of a tissue-specific CDP/ Cux isoform, p75, activated in breast tumor cells. Cancer Res. 62, 6625-6633.
20. Grove, E. A., Tole, S., Limon, J., Yip, L. and Ragsdale, C. W. (1998). The hem of the embryonic cerebral cortex is defined by the expression of multiple Wnt genes and is compromised in Gli3-deficient mice. Development 125, 2315-2325.
21. Harada, R., Bérubé, G., Tamplin, O. J., Denis-Larose, C. and Nepveu, A. (1995). DNA-binding specificity of the cut repeats from the human cut-like protein. Mol. Cell. Biol. 15, 129-140.
22. Harada, R., Vadnais, C., Sansregret, L., Leduy, L., Bérubé, G., Robert, F. and Nepveu, A. (2008). Genome-wide location analysis and expression studies reveal a role for p110 CUX1 in the activation of DNA replication genes. Nucleic Acids Res. 36, 189-202.
23. He, T. C., Sparks, A. B., Rago, C., Hermeking, H., Zawel, L., da Costa, L. T., Morin, P. J., Vogelstein, B. and Kinzler, K. W. (1998). Identification of c-MYC as a target of the APC pathway. Science 281, 1509-1512.
24. Hoang, B., Moos, M., Jr, Vukicevic, S. and Luyten, F. P. (1996). Primary structure and tissue distribution of FRZB, a novel protein related to Drosophila frizzled, suggest a role in skeletal morphogenesis. J. Biol. Chem. 271, 26131-26137.
25. Hsieh, J. C., Kodjabachian, L., Rebbert, M. L., Rattner, A., Smallwood, P. M., Samos, C. H., Nusse, R., Dawid, I. B. and Nathans, J. (1999). A new secreted protein that binds to Wnt proteins and inhibits their activities. Nature 398, 431-436.
26. Hulea, L. and Nepveu, A. (2012). CUX1 transcription factors: from biochemical activities and cell-based assays to mouse models and human diseases. Gene 497, 18-26.
27. Kedinger, V. and Nepveu, A. (2010). The roles of CUX1 homeodomain proteins in the establishment of a transcriptional program required for cell migration and invasion. Cell Adh. Migr. 4, 348-352.
28. Kedinger, V., Sansregret, L., Harada, R., Vadnais, C., Cadieux, C., Fathers, K., Park, M. and Nepveu, A. (2009). p110 CUX1 homeodomain protein stimulates cell migration and invasion in part through a regulatory cascade culminating in the repression of E-cadherin and occludin. J. Biol. Chem. 284, 27701-27711.
29. Lee, K. A., Bindereif, A. and Green, M. R. (1988). A small-scale procedure for preparation of nuclear extracts that support efficient transcription and pre-mRNA splicing. Gene Anal. Tech. 5, 22-31.
30. Lesurf, R. (2008). Molecular Pathway Analysis of Mouse Models for Breast Cancer. MSc thesis, School of Computer Science, McGill University, Montreal, QC, Canada.
31. Li, Y., Hively, W. P. and Varmus, H. E. (2000). Use of MMTV-Wnt-1 transgenic mice for studying the genetic basis of breast cancer. Oncogene 19, 1002-1009.
32. Li, X., Deng, W., Lobo-Ruppert, S. M. and Ruppert, J. M. (2007). Gli1 acts through Snail and E-cadherin to promote nuclear signaling by beta-catenin. Oncogene 26, 4489-4498.
33. Lichti-Kaiser, K., ZeRuth, G., Kang, H. S., Vasanth, S. and Jetten, A. M. (2012). Gli-similar proteins: their mechanisms of action, physiological functions, and roles in disease. Vitam. Horm. 88, 141-171.
34. Liu, X., Mazanek, P., Dam, V., Wang, Q., Zhao, H., Guo, R., Jagannathan, J., Cnaan, A., Maris, J. M. and Hogarty, M. D. (2008). Deregulated Wnt/betacatenin program in high-risk neuroblastomas without MYCN amplification. Oncogene 27, 1478-1488.
35. MacDonald, B. T., Tamai, K. and He, X. (2009). Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev. Cell 17, 9-26.
36. Maekawa, M., Yamaguchi, K., Nakamura, T., Shibukawa, R., Kodanaka, I., Ichisaka, T., Kawamura, Y., Mochizuki, H., Goshima, N. and Yamanaka, S. (2011). Direct reprogramming of somatic cells is promoted by maternal transcription factor Glis1. Nature 474, 225-229.
37. Micchelli, C. A., Rulifson, E. J. and Blair, S. S. (1997). The function and regulation of cut expression on the wing margin of Drosophila: Notch, Wingless and a dominant negative role for Delta and Serrate. Development 124, 1485-1495.
38. Michl, P. and Downward, J. (2006). CUTL1: a key mediator of TGFbeta-induced tumor invasion. Cell Cycle 5, 132-134.
39. Michl, P., Ramjaun, A. R., Pardo, O. E., Warne, P. H., Wagner, M., Poulsom, R., D'Arrigo, C., Ryder, K., Menke, A., Gress, T. et al. (2005). CUTL1 is a target of TGF(beta) signaling that enhances cancer cell motility and invasiveness. Cancer Cell 7, 521-532.
40. Moon, N. S., Bérubé, G. and Nepveu, A. (2000). CCAAT displacement activity involves CUT repeats 1 and 2, not the CUT homeodomain. J. Biol. Chem. 275, 31325-31334.
41. Moon, N. S., Premdas, P., Truscott, M., Leduy, L., Bérubé, G. and Nepveu, A. (2001). S phase-specific proteolytic cleavage is required to activate stable DNA binding by the CDP/Cut homeodomain protein. Mol. Cell. Biol. 21, 6332-6345.
42. Mullor, J. L., Dahmane, N., Sun, T. and Ruiz i Altaba, A. (2001). Wnt signals are targets and mediators of Gli function. Curr. Biol. 11, 769-773.
43. Nepveu, A. (2001). Role of the multifunctional CDP/Cut/Cux homeodomain transcription factor in regulating differentiation, cell growth and development. Gene 270, 1-15.
44. Neumann, C. J. and Cohen, S. M. (1996). A hierarchy of cross-regulation involving Notch, wingless, vestigial and cut organizes the dorsal/ventral axis of the Drosophila wing. Development 122, 3477-3485.
45. Nusse, R. (2008). Wnt signaling and stem cell control. Cell Res. 18, 523-527.
46. Ponzo, M. G., Lesurf, R., Petkiewicz, S., O'Malley, F. P., Pinnaduwage, D., Andrulis, I. L., Bull, S. B., Chughtai, N., Zuo, D., Souleimanova, M. et al. (2009). Met induces mammary tumors with diverse histologies and is associated with poor outcome and human basal breast cancer. Proc. Natl. Acad. Sci. USA 106, 12903-12908.
47. Rak, J. W., Basolo, F., Elliott, J. W., Russo, J. and Miller, F. R. (1991). Cell surface glycosylation changes accompanying immortalization and transformation of normal human mammary epithelial cells. Cancer Lett. 57, 27-36.
48. Ramdzan, Z. M., Vadnais, C., Pal, R., Vandal, G., Cadieux, C., Leduy, L., Davoudi, S., Hulea, L., Yao, L., Karnezis, A. N. et al. (2014). RAS transformation requires CUX1-dependent repair of oxidative DNA damage. PLoS Biol. 12, e1001807.
49. Riobo, N. A. and Manning, D. R. (2007). Pathways of signal transduction employed by vertebrate Hedgehogs. Biochem. J. 403, 369-379.
50. Ripka, S., König, A., Buchholz, M., Wagner, M., Sipos, B., Klöppel, G., Downward, J., Gress, T. and Michl, P. (2007). WNT5A - target of CUTL1 and potent modulator of tumor cell migration and invasion in pancreatic cancer. Carcinogenesis 28, 1178-1187.
51. Ripka, S., Neesse, A., Riedel, J., Bug, E., Aigner, A., Poulsom, R., Fulda, S., Neoptolemos, J., Greenhalf, W., Barth, P. et al. (2010). CUX1: target of Akt signalling and mediator of resistance to apoptosis in pancreatic cancer. Gut 59, 1101-1110.
52. Sansregret, L. and Nepveu, A. (2008). The multiple roles of CUX1: insights from mouse models and cell-based assays. Gene 412, 84-94.
53. Sansregret, L., Goulet, B., Harada, R., Wilson, B., Leduy, L., Bertoglio, J. and Nepveu, A. (2006). The p110 isoform of the CDP/Cux transcription factor accelerates entry into S phase. Mol. Cell. Biol. 26, 2441-2455.
54. Sansregret, L., Vadnais, C., Livingstone, J., Kwiatkowski, N., Awan, A., Cadieux, C., Leduy, L., Hallett, M. T. and Nepveu, A. (2011). Cut homeobox 1 causes chromosomal instability by promoting bipolar division after cytokinesis failure. Proc. Natl. Acad. Sci. USA 108, 1949-1954.
55. Schlange, T., Matsuda, Y., Lienhard, S., Huber, A. and Hynes, N. E. (2007). Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation. Breast Cancer Res. 9, R63.
56. Segditsas, S. and Tomlinson, I. (2006). Colorectal cancer and genetic alterations in the Wnt pathway. Oncogene 25, 7531-7537.
57. Semenov, M. V. and He, X. (2006). LRP5 mutations linked to high bone mass diseases cause reduced LRP5 binding and inhibition by SOST. J. Biol. Chem. 281, 38276-38284.
58. Sheng, H., Goich, S., Wang, A., Grachtchouk, M., Lowe, L., Mo, R., Lin, K., de Sauvage, F. J., Sasaki, H., Hui, C. C. et al. (2002). Dissecting the oncogenic potential of Gli2: deletion of an NH(2)-terminal fragment alters skin tumor phenotype. Cancer Res. 62, 5308-5316.
59. Smyth, G. K. (2005). Limma: linear models for microarray data. In Bioinformatics and Computational Biology Solutions Using R and Bioconductor (ed. R. Gentleman, V. Carey, S. Dudoit, R. Irizarry and W. Huber), pp. 397-420. New York: Springer.
60. Truscott, M., Denault, J. B., Goulet, B., Leduy, L., Salvesen, G. S. and Nepveu, A. (2007). Carboxyl-terminal proteolytic processing of CUX1 by a caspase enables transcriptional activation in proliferating cells. J. Biol. Chem. 282, 30216-30226.
61. Vadnais, C., Davoudi, S., Afshin, M., Harada, R., Dudley, R., Clermont, P. L., Drobetsky, E. and Nepveu, A. (2012). CUX1 transcription factor is required for optimal ATM/ATR-mediated responses to DNA damage. Nucleic Acids Res. 40, 4483-4495.
62. Vijayakumar, S., Liu, G., Rus, I. A., Yao, S., Chen, Y., Akiri, G., Grumolato, L. and Aaronson, S. A. (2011). High-frequency canonical Wnt activation in multiple sarcoma subtypes drives proliferation through a TCF/b-catenin target gene, CDC25A. Cancer Cell 19, 601-612.
63. Von Ohlen, T. and Hooper, J. E. (1997). Hedgehog signaling regulates transcription through Gli/Ci binding sites in the wingless enhancer. Mech. Dev. 68, 149-156.
64. Wilcoxon, F. (1945). Individual comparisons by ranking methods. Biometrics Bulletin 1, 80-83.
65. Xu, J., Suzuki, M., Niwa, Y., Hiraga, J., Nagasaka, T., Ito, M., Nakamura, S., Tomita, A., Abe, A., Kiyoi, H. et al. (2008). Clinical significance of nuclear nonphosphorylated beta-catenin in acute myeloid leukaemia and myelodysplastic syndrome. Br. J. Haematol. 140, 394-401.
66. Yan, L., Della Coletta, L., Powell, K. L., Shen, J., Thames, H., Aldaz, C. M. and MacLeod, M. C. (2011). Activation of the canonical Wnt/b-catenin pathway in ATF3-induced mammary tumors. PLoS ONE 6, e16515.